- Vouliez-vous dire
- effect
Résultats de la recherche - 3124 results
The phage-encoded PIT4 protein affects multiple two-component systems of Pseudomonas aeruginosa
the development of an anti-virulence compound that targets the bacterial TCS. Health Topics: Effectiveness and safety of vaccines, medicines and health products- Quality of medical laboratories ...
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium
Publication Type: Peer reviewed scientific article Authors: Elias Vermeiren; Joris Van Loenhout; Léonore Nasiadka; Veerle Stouten; Matthieu Billuart; Izaak Van Evercooren; Lucy Catteau; Pierre Hubin Source: BMC Res Notes, Volume 16, Issue 1 (2023) Keyword ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Humans REGISTRIES Vaccine Efficacy Abstract: BACKGROUND: Within the ECDC- VEBIS project, we prospectively monitored vaccine effectiveness (VE) against COVID-19 hospitalisation and COVID-19-related death ...
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
Publication Type: Peer reviewed scientific article Authors: Meslé, Margaux M I; Sinnathamby, Mary; Mook, Piers; WHO European Region Respiratory Network Group; Pebody, Richard; Lakhani, Anissa; Zambon, Maria; Popovici, Odette; Lazar, Mihaela; Ljubović, Ame ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
effectiveness (VE) in participating European countries since early 2021.AimWe aimed to measure VE against PCR-confirmed SARS-CoV-2 in patients ≥ 20 years hospitalised with severe acute respiratory infection ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Efficacy Abstract: IntroductionTwo large multicentre European hospital networks have estimated vaccine effectiveness (VE) against COVID-19 since 2021.AimWe aimed to measure VE against PCR-confirmed ...
Development of novel analytical methods to trace small micro- and nanoplastics in food matrices
strength, or barrier activity against oxygen and carbon dioxide, and the cost-effectiveness. However, apart from macroplastics, we are facing with the serious problem of microplastics (MP s) and nanoplastics ...
Federated causal inference based on real-world observational data sources: application to a SARS-CoV-2 vaccine effectiveness assessmentAbstractIntroductionMethodsResultsConclusions
framework was demonstrated and an analytical pipeline implementing federated causal inference was prototyped using open-source software in preparation for the assessment of real-world effectiveness of ...
Aetiological and prognostic roles of frailty, multimorbidity and socioeconomic characteristics in the development of SARS-CoV-2 health outcomes: protocol for systematic reviews of population-based studies
lower socioeconomic status. Existing reviews focus on few, mainly short-term effects of COVID-19 illness and patients with single chronic disease. Information is also largely missing for population ...
Report of WHO Drafting Group meeting to revise WHO Guidelines on procedures and data requirements for changes to approved vaccines
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: L. Tesolin; H. Meyer; D. Lei; T. Jivapaisarnpong; M. Welin; A. Cheung Source: WHO, Geneva, switzerland, p.9 (2023) Health Topics: Vaccine batch conformity Vaccin lo ...